New Key Statistics Module, Z-Score and F-Score
XCNQ:NOVA Key Ratios
Market Cap C$ M | 0.74 |
Enterprise Value C$ M | 0.79 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | -- |
Price/Sales | -- |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) C$ M | -- |
EPS (TTM) C$ | -0.003 |
Beneish M-Score | 0 |
10-y EBITDA Growth Rate % | 17.30 |
5-y EBITDA Growth Rate % | 32.30 |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -1.85 |
EV-to-EBITDA | -1.86 |
PEG | -- |
Shares Outstanding M | 148.32 |
Net Margin (%) | -1,496.43 |
Operating Margin % | -1,528.57 |
Pre-tax Margin (%) | -1,496.43 |
Quick Ratio | 0.01 |
Current Ratio | 0.01 |
ROA % (ttm) | -1,047.50 |
ROE % (ttm) | -- |
ROIC % (ttm) | -839.22 |
Dividend Yield % | -- |
Altman Z-Score | -3,344.02 |
XCNQ:NOVA Number of Guru Trades
XCNQ:NOVA Volume of Guru Trades
Gurus Latest Trades with XCNQ:NOVA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
XCNQ:NOVA is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Nova Mentis Life Science Corp Insider Transactions
No Available Data